ALL PSYCHEDELIC AND PSYCHEDELIC STOCK NEWS

Small Pharma (DMTTF) Successfully Completes Phase I Clinical Trial Of DMT In Combination With Supportive Psychotherapy

Small Pharma's DMT-assisted therapy (SPL026) demonstrated to be well-tolerated and safe in psychedelic naïve volunteers Dataset generated from Phase...

Huge News on Opioid Addiction From atai (ATAI).

Every successful drug was once in Phase I. "In previously published non-controlled studies, ibogaine has demonstrated rapid and...

AdvisorShares Psychedelics ETF (PSIL)

The AdvisorShares Psychedelics ETF (NYSE ticker: PSIL) invests in the emerging psychedelic drugs sector, offering exposure to those biotechnology, pharmaceutical and life sciences companies...

Ketamine One (KONEF) Signs LOI with Veteran Services USA to Open Therapy Center

Ketamine-Assisted Treatment Facility to Be Part of a Medical Complex in Blue Island, Illinois

atai Life Sciences (ATAI) Increases Investment in IntelGenx’s (IGXT).

atai Life Sciences Increases Loan in Principal by US$6m to Support IntelGenx’s Graduation to Toronto Stock Exchange After Positive Early Feasibility...

Novamind (NVMDF) Announces Inclusion in NYSE Listed AdvisorShares Psychedelics ETF (PSIL)

(CSE: NM) TORONTO, ON / ACCESSWIRE / September 20, 2021 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental...

Horizons Psychedelic Index ETF.

CLICK TO VIEW WEBSITE PRODUCT SHEET

On-Demand Now: Life Sciences Psychedelic Company Presentations.

The presentations from their recent live event are now available for replay. The event featured CEOs and top executives from international companies engaged...

AdvisorShares Launches Psychedelics ETF (Ticker: PSIL)

AdvisorShares Psychedelics ETF delivers focused exposure to invest in a new medical frontier BETHESDA, Md., Sept. 16, 2021 /PRNewswire/ -- AdvisorShares, a...

Ehave (EHVVF) Announces Update On Ehave Medical App With The Launch Of Covid Vaccine Passport Going Live Shortly

Ehave's Covid Passport provides small businesses a tool to verify Covid-19 vaccination, and a suite of products to improve both the mental...

NeonMind (NMBDF) Announces Divestiture of Consumer Related and Other Non-Core Assets

CSE: (NEON) LIVE QUOTE Reflects Strategic Focus on Psychedelic Treatments...

Lobe Sciences (GTSIF) Provides Corporate Update to Investors and Stakeholders

CSE symbol (LOBE). LIVE QUOTE Vancouver, British Columbia–(Newsfile Corp. –...

Ketamine One (KONEF) Signs LOI for Two Ketamine Infusion Clinics in Texas

The Arrangement Bolsters the Company’s Proposed Network of Six Clinics in the United States VANCOUVER, British Columbia, Sept. 08,...

KetaDash

Ketamine at Home Treatments
RESEARCH

Most Popular

Psychedelic Drugs ‘Far Exceed’ Cannabis Investment Potential (CNBC)

Shark Tank’s Kevin O’Leary, Wesana (WSNAF) CEO Daniel Carcillo and director at Mass General Hospital’s Center for the Neuroscience of Psychedelics Dr....

Psychedelic Therapeutics Sector Outlook Released (Valhalla Ventures)

Valhalla Ventures backs visionary founders at the forefront of social and technological movements that younger generations care about most.

2021 Psychedelic Investor Guide Released.

Institutional Analyst Inc. announced the release of the 2021 Psychedelic Investor Guide on Monday, October 18th. The Psychedelic Investor Guide is the...

LARGE CAP PSYCHEDELIC STOCKS

PSYCHEDELIC FUNDS AND ETFS